Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALPL | P05186 | 2/20 | 0.37 |
| ▸ | PLAA | Q9Y263 | 1/20 | 0.37 |
| ▸ | ALPG | P10696 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | QPCT | Q16769 | 2/20 | 0.35 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.33 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL28926580 | 0.77 | — | — | |
| Phosphoric Acid SCHEMBL3326759 | 0.76 | ALPL (0.42) | KMT2AALPLPLAAALPGQPCT | |
| SCHEMBL28137214 | 0.73 | CA12 (0.36) | KMT2ASMN1; SMN2GAA | |
| SCHEMBL25210345 | 0.72 | CYP3A4 (0.42) | KMT2AALPLPLAAALPGQPCT | |
| SCHEMBL466166 | 0.71 | ALDH1A1 (0.41) | ALDH1A1 | |
| SCHEMBL2065791 | 0.71 | — | — | |
| SCHEMBL21233104 | 0.69 | KMT2A (0.40) | KMT2AALPLPLAAALPGALDH1A1 | |
| SCHEMBL9032506 | 0.69 | CYP2E1 (0.40) | KMT2ACYP2E1CYP3A4CYP2A6CYP2C9 | |
| SCHEMBL3711683 | 0.69 | RAB9A (0.54) | KMT2AALPLPLAAALPGALDH1A1 | |
| SCHEMBL18264169 | 0.69 | KMT2A (0.44) | KMT2AALPLPLAAALPGALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260086079-A1 | FUNCTIONALIZED GRAPHENE AND METHODS OF USE THEREOF | HUMMER MATTHEW (US) | 2026-03-26 | — | — | US | disclosed |
| US-20250066628-A1 | GRAPHENE INK COMPOSITION AND METHODS OF USE THEREOF | HUMMER MATTHEW (US) | 2025-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260086079-A1 | FUNCTIONALIZED GRAPHENE AND METHODS OF USE THEREOF | EPCAM, SAMM50, SCO2 | KMT2A 4863/4885ALPL 1886/4885PLAA 3131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.